Nephros, Inc. (NASDAQ:NEPH) Sees Significant Drop in Short Interest

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 8,300 shares, a drop of 13.5% from the February 13th total of 9,600 shares. Based on an average trading volume of 13,400 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.1% of the shares of the stock are short sold.

Nephros Stock Performance

Shares of Nephros stock opened at $1.50 on Friday. The business’s 50 day moving average price is $1.56 and its 200 day moving average price is $1.58. The company has a market cap of $15.82 million, a price-to-earnings ratio of -16.67 and a beta of 1.19. Nephros has a one year low of $1.36 and a one year high of $2.55.

Hedge Funds Weigh In On Nephros

An institutional investor recently bought a new position in Nephros stock. Topline Capital Management LLC purchased a new position in Nephros, Inc. (NASDAQ:NEPH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned about 3.98% of Nephros as of its most recent SEC filing. Institutional investors and hedge funds own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.